The Indian government is considering tighter regulations for manufacturers and suppliers of printed pharmaceutical packaging materials as part of a broader effort to combat the growing circulation of counterfeit medicines.
The United States has launched a formal investigation into Germany under Section 301 of the Trade Act of 1974, examining whether the country’s pricing policies for innovative pharmaceutical products are discriminatory
